- Report
- October 2023
- 85 Pages
United States
From €4270EUR$4,850USD£3,690GBP
- Report
- January 2021
- 38 Pages
Global
€1160EUR$1,318USD£1,003GBP
- Report
- August 2024
- 69 Pages
Global
From €3500EUR$4,259USD£3,131GBP
- Report
- November 2024
- 89 Pages
Global
From €3500EUR$4,259USD£3,131GBP
- Report
- March 2024
- 111 Pages
Global
From €3500EUR$4,259USD£3,131GBP
From €105EUR$119USD£91GBP
- Book
- February 2020
- 459 Pages
From €114EUR$129USD£98GBP
- Book
- August 2023
North America

The Inflammation market within the context of Allergy and Immunology is a rapidly growing field of research and development. It focuses on the study of the body's immune system and its response to allergens, pathogens, and other foreign substances. This includes the development of treatments and therapies to reduce inflammation and improve the body's ability to fight off infection. The market is driven by the increasing prevalence of allergies and autoimmune diseases, as well as the need for more effective treatments.
The Inflammation market is composed of a variety of companies, ranging from pharmaceuticals to biotechnology firms. These companies are focused on developing new treatments and therapies to reduce inflammation and improve the body's ability to fight off infection. Examples of companies in this market include AbbVie, AstraZeneca, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more